Validation of an Urticaria Control Test (UCT-V)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by Charite University, Berlin, Germany.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
K. Weller, Charite University, Berlin, Germany Identifier:
First received: June 6, 2012
Last updated: February 14, 2013
Last verified: February 2013
The aim of this study is to validate a previously developed patient reported outcome instrument (in project UCT-D) to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.

Chronic Urticaria

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Development (and Validation) of an Instrument to Assess Disease Control in Patients With Urticaria (Urticaria Control Test)

Resource links provided by NLM:

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Urticaria activity

Estimated Enrollment: 100
Study Start Date: July 2012
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
chronic urticaria patients
all patients suffering from chronic forms of urticaria (chronic spontaneous urticaria as well as chronic inducible forms such as cold contact urticaria)


Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients suffering from chronic forms of urticaria
all patients suffering from chronic forms of urticaria are eligible
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01614834

Contact: Karsten Weller, MD
Contact: Marcus Maurer, MD

Universitätshautklinik Mainz Not yet recruiting
Mainz, Rheinland-Pfalz, Germany, 55131
Contact: Petra Staubach, MD   
Principal Investigator: Petra Staubach, MD         
Allergie-Centrum-Charite Recruiting
Berlin, Germany, 10117
Contact: Karsten Weller, MD   
Principal Investigator: Karsten Weller, MD         
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: K. Weller, Pricipal Investigator, Charite University, Berlin, Germany Identifier: NCT01614834     History of Changes
Other Study ID Numbers: UCT-V
Study First Received: June 6, 2012
Last Updated: February 14, 2013
Health Authority: Germany: Ethics Commission

Keywords provided by Charite University, Berlin, Germany:
disease control

Additional relevant MeSH terms:
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Vascular processed this record on November 27, 2015